Last reviewed · How we verify
Episcleral Topotecan
At a glance
| Generic name | Episcleral Topotecan |
|---|---|
| Also known as | Episcleral Topotecan, Transscleral Topotecan, Sustained Release Episcleral Topotecan, Chemoplaque |
| Sponsor | Targeted Therapy Technologies, LLC |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Episcleral Topotecan CI brief — competitive landscape report
- Episcleral Topotecan updates RSS · CI watch RSS
- Targeted Therapy Technologies, LLC portfolio CI